miR221 can regulate the STAT3/Akt pathway, the tumour suppressor p27Kip1 in glioma cells [44, 45] and can interfere with the p53/Bcl-2/PUMA, p27Kip1 and TGF-β signalling [46, 47]. This evidence concerns the gene CDKN1B and central nervous system cancer.